Align Technology, Inc. upgraded to Hold after a 30% drop; weak growth and margins persist despite guidance. Click for this ...
CEO Joe Hogan highlighted Q4 2024 revenue of $995 million, reflecting 4% year-over-year growth. Clear aligner volumes ...
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $179.17, with a ...
CEO Joe Hogan reported Q1 revenues, operating margin, and earnings were in line with the company’s outlook. Clear Aligner volumes increased sequentially and year-over-year, with notable growth in the ...
Shares of Align Technology Inc. ALGN advanced 2.66% to $169.95 Wednesday, on what proved to be an all-around positive trading ...
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ ...
Tempe, Arizona-based Align Technology, Inc. (ALGN) is a leader in medical devices, renowned for its Invisalign clear aligners and iTero intraoral scanners. With a market cap of $12.4 billion, Align ...
New professional marketing initiative celebrates the role doctors play in digital orthodontics and provides a platform to inspire others through their personal stories. Initiative underscores Align’s ...
BofA raised the firm’s price target on Align Technology (ALGN) to $206 from $200 and keeps an Underperform rating on the shares. The Life Sciences Tools sector underperformed again in FY24 as Pharma ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results